M3 (2413.T) Azione Prezzo

M3 Inc is primarily active in the healthcare and information technology (IT) industries.

M3 Inc faces competition from various companies in the market. Some of the main competitors of M3 Inc include IQVIA Holdings Inc, Veeva Systems Inc, and Cerner Corporation. These companies offer similar products and services, targeting the healthcare industry. However, M3 Inc distinguishes itself by providing innovative solutions and platforms tailored specifically for healthcare professionals. As a trusted name in the market, M3 Inc continues to compete and thrive in the ever-evolving industry, delivering comprehensive solutions to meet the needs of healthcare professionals efficiently and effectively.

M3 Inc is a leading Japanese company specializing in healthcare services and online physician communities. Established in 2000, M3 Inc has rapidly grown to become one of the largest players in the healthcare industry. M3 Inc's innovative platform provides healthcare professionals with valuable resources, such as medical information, education, and market research opportunities. The company is committed to improving the healthcare system and enhancing patient care through its technological advancements. With a strong focus on collaboration and networking, M3 Inc continues to lead the way in revolutionizing the healthcare industry in Japan and beyond.

M3 Inc has achieved several significant milestones in its journey. One notable milestone includes the company's establishment in 2000 as a provider of medical information and services. Another milestone is the successful launch of M3's online physician community platform, MDLinx, which has grown to become one of the largest global networks of healthcare professionals. Additionally, M3 Inc expanded its reach by establishing international offices and acquiring several healthcare-related companies to enhance its product and service offerings. The company's commitment to innovation and collaboration has propelled M3 Inc to become a trusted leader in the healthcare industry.

M3 Inc is primarily present in Japan, where it is headquartered. As a leading provider of healthcare services, M3 Inc also has a strong presence in the United States, China, South Korea, and various other Asian countries. With its global reach and extensive network, M3 Inc has established a strong foothold in the medical industry, connecting healthcare professionals, pharmaceutical companies, and institutions across different countries and regions.

M3 Inc represents a set of core values and a corporate philosophy that guide its operations. As a leading company in the healthcare industry, M3 Inc focuses on three key values: innovation, integrity, and impact. With a commitment to delivering innovative solutions and services, M3 Inc strives to stay at the forefront of advancements in healthcare technology. The company's strong emphasis on integrity ensures transparent and ethical conduct in all business dealings. Moreover, M3 Inc aims to create a positive impact on healthcare professionals and society as a whole through its products and services. These values and corporate philosophy drive M3 Inc's mission to improve healthcare globally.

Gli analisti fissano attualmente un prezzo obiettivo medio di 2673,18 JPY per l’azione M3 (mediana: 2652,00 JPY), pari a +43,6 % rispetto all’ultimo prezzo. Il consenso si basa su 19 giudizi di analisti.

M3 Prezzi Obiettivo Analisti 2026

19 analisti valutano attualmente l’azione M3: 13 raccomandano l’acquisto, 6 la tenuta e 0 la vendita.

M3 Prezzi Obiettivo Analisti 2026

Convertita al tasso di cambio attuale, l’azione M3 quota 10,59 EUR (1862,00 JPY).

L’azione M3 (2413.T) è quotata su 6 borse, tra cui: Tokio (JPX) (2413.T), Frankfurt (4YC.F), München (4YC.MU), Düsseldorf (4YC.DU).

M3 Inc is a leading company in the healthcare IT and medical services industry. Their business model is based on various divisions, including providing online networks for doctors, medical imaging, e-health, clinical research, and pharmaceutical advertising. One of M3's main activities is providing online networks for doctors, including their flagship product M3.com. The network serves as a discussion forum, continuing education platform, and market research tool for doctors. It allows doctors to connect with colleagues, access scientific research, and participate in clinical trials. The platform also offers a specialized job board for medical professionals. Medical imaging is a key business area for M3. They offer radiology solutions for hospitals and clinics, including a complete workflow management platform and a PACS (Picture Archiving and Communication System) for storing, transmitting, and archiving medical images. The company also provides point-of-care systems for quick diagnosis and treatment of patients. Another focus is e-health. Here, M3 offers a variety of products and services, including the development of mobile and web-based applications that collect, store, and analyze health data. Such solutions include telemedicine, patient portals, online medical records, and patient apps designed to facilitate daily care. Clinical research is another important business field for M3. The company provides a platform for patient recruitment for clinical studies. They work closely with pharmaceutical and biotech companies to accelerate patient access and streamline the clinical research process. This platform enables doctors to directly contact potential patients who may be eligible for a specific clinical trial. Finally, M3 is also involved in pharmaceutical advertising and sales promotion. The company offers a variety of marketing solutions for pharmaceutical and biotech firms, including internet advertising, direct marketing via email, telephone marketing, and other digital or social media. Additionally, the company has comprehensive market research tools that allow its clients to obtain accurate analysis of the healthcare industry. In summary, M3 offers a wide range of products and services in the field of medical services and healthcare IT. The company has a strong presence in Japan and is also expanding into other countries, particularly the United States and Europe. With its comprehensive product range and strong market position, M3 is well positioned to benefit from the strong growth of the healthcare sector worldwide.

Il fatturato di M3 ammonta a 351,36 miliardi JPY. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.

Il profitto di M3 ammonta a 49,10 miliardi JPY. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.

Il rapporto prezzo/utili (P/E) di M3 è attualmente 25,32. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione M3.

Il rapporto prezzo/fatturato (P/S) di M3 è attualmente 3,54. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione M3.

Il Quality Score AlleAktien per M3 è 7/10.

L'ISIN di M3 è JP3435750009. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.

Il WKN di M3 è A0B8RE. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.

Il ticker di M3 è 2413.T. Con questo simbolo di borsa vengono negoziate le azioni M3 in borsa.